mRNA |
Bosutinib |
FIMM |
pan-cancer |
AAC |
-0.0029 |
1 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.00027 |
1 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.00023 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00019 |
1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00017 |
1 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.00016 |
1 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-5.6e-05 |
1 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
4.2e-05 |
1 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-1.6e-05 |
1 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-7.3e-06 |
1 |